183 related articles for article (PubMed ID: 15104062)
1. TRIPS from Doha to Cancún ... to Ottawa: global developments in access to treatment and Canada's Bill C-56.
Elliott R
Can HIV AIDS Policy Law Rev; 2003 Dec; 8(3):1, 7-18. PubMed ID: 15104062
[TBL] [Abstract][Full Text] [Related]
2. Steps forward, backward, and sideways: Canada's bill on exporting generic pharmaceuticals.
Elliott R
HIV AIDS Policy Law Rev; 2004 Dec; 9(3):15-21. PubMed ID: 15801105
[TBL] [Abstract][Full Text] [Related]
3. Canada ordered to implement WTO ruling against "stockpiling" of generic drugs.
Elliott R
Can HIV AIDS Policy Law Rev; 2000; 5(4):27. PubMed ID: 11833161
[TBL] [Abstract][Full Text] [Related]
4. Mixed WTO ruling on generic drug development.
Elliott R
Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):38-42, 40-4. PubMed ID: 11833195
[TBL] [Abstract][Full Text] [Related]
5. Will they deliver treatment access?: WTO rules and Canada's law on generic medicine exports.
Elliott R
HIV AIDS Policy Law Rev; 2006 Dec; 11(2-3):13-6. PubMed ID: 17373059
[TBL] [Abstract][Full Text] [Related]
6. A one-time-only combination: Emergency medicine exports and the TRIPS agreement under Canada's access to medicines regime.
Weber A; Mills L
Health Hum Rights; 2010 Jun; 12(1):109-22. PubMed ID: 20930258
[TBL] [Abstract][Full Text] [Related]
7. Bill C-30: who wins and who loses in Canada's pharmaceutical patent battles?
Hollis A
Expert Opin Ther Pat; 2018 Jan; 28(1):1-3. PubMed ID: 28974123
[No Abstract] [Full Text] [Related]
8. First test of WTO mechanism for procuring generic medicines under compulsory licence, via Canada's Access to Medicines Regime.
Elliott R
HIV AIDS Policy Law Rev; 2007 Dec; 12(2-3):23-5. PubMed ID: 18459195
[TBL] [Abstract][Full Text] [Related]
9. Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001-2016.
't Hoen EF; Veraldi J; Toebes B; Hogerzeil HV
Bull World Health Organ; 2018 Mar; 96(3):185-193. PubMed ID: 29531417
[TBL] [Abstract][Full Text] [Related]
10. Action on Canada's generic drug law.
Abi-Jaoude E
CMAJ; 2004 Apr; 170(9):1374; author reply 1374-5. PubMed ID: 15111456
[No Abstract] [Full Text] [Related]
11. Health policy or intellectual property policy? The fight over Bill C-91. Canadian Healthcare Association.
Int J Health Care Qual Assur Inc Leadersh Health Serv; 1997; 10(2-3):vii-x. PubMed ID: 10169229
[TBL] [Abstract][Full Text] [Related]
12. Amendments to the Canadian Patent Act to address drug access: is help on the way?
Penner MD; Narayanan P
Food Drug Law J; 2005; 60(3):459-70. PubMed ID: 16304751
[No Abstract] [Full Text] [Related]
13. Removing barriers? An overview of the Canadian Access to Medicines Regime.
Penner MD; Armstrong PG
Health Law Can; 2008 Jun; 28(3-4):112-22. PubMed ID: 19051971
[TBL] [Abstract][Full Text] [Related]
14. Canada and access to medicines in developing countries: intellectual property rights first.
Lexchin J
Global Health; 2013 Sep; 9():42. PubMed ID: 24007595
[TBL] [Abstract][Full Text] [Related]
15. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
[TBL] [Abstract][Full Text] [Related]
16. WTO approves TRIPS amendment on importing under compulsory licensing.
Herget G
HIV AIDS Policy Law Rev; 2006 Apr; 11(1):23-4. PubMed ID: 16805011
[TBL] [Abstract][Full Text] [Related]
17. An exploration of compulsory licensing as an effective policy tool for antiretroviral drugs in India.
Jain D; Darrow JJ
Health Matrix Clevel; 2013; 23(2):425-57. PubMed ID: 24341078
[TBL] [Abstract][Full Text] [Related]
18. Balancing public health, trade and intellectual monopoly privileges: recent Australian IP legislation and the TPPA.
Vines T; Crow K; Faunce T
J Law Med; 2012 Dec; 20(2):280-94. PubMed ID: 23431847
[TBL] [Abstract][Full Text] [Related]
19. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
20. India: New patent law may restrict access to HIV/AIDS treatments.
Cruess G
HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
